Remove Innovation Remove Outcomes Remove Technology
article thumbnail

HRS 2024: Innovation Meets Reality

DAIC

Innovation in medical technology exists to improve patient outcomes, increase surgical efficiency and enhance patient safety. Infrequently, we see medical technology innovation of a paradigmatic nature that changes the way physicians approach disease states and dramatically improve results.

article thumbnail

Innovative Imaging Technology Leads Top Trends of 2023

Cassling

We continue to be amazed by the imaging teams around the country who commit so much of themselves to improving patient outcomes. Insights into technology and what the future holds for MRI, CT and more were among our most viewed articles by far. What a year it’s been! We’ll continue to bring you these insights and many more in 2024.

article thumbnail

Heart Rhythm Society’s HRX 2024 to Draw Cardiovascular Innovators to Atlanta

DAIC

The Heart Rhythm Society (HRS) is preparing for HRX 2024, the third annual event of its kind, which will be held from September 5-7, 2024, in Atlanta, GA, gathering cardiovascular health innovators together to explore discoveries and advance partnerships between medicine and technology. On Thursday, Sept.

article thumbnail

Narrative review: updates and strategies for reducing door-to-balloon time in ST-elevation myocardial infarction care

Frontiers in Cardiovascular Medicine

This narrative review aims to evaluate strategies for reducing door-to-balloon (D2B) time in ST-elevation myocardial infarction (STEMI) patients, focusing on pre-hospital, in-hospital, and technological innovations, as well as addressing challenges to ensure sustainability.

article thumbnail

CTA and ACC Collaborate to Tackle Cardiovascular Disease with Technology

DAIC

milla1cf Wed, 02/07/2024 - 18:05 February 7, 2024 — The Consumer Technology Association ( CTA ) and the American College of Cardiology ( ACC ) are announcing the release of their second industry framework for the use of consumer cardiovascular technology solutions in the screening and diagnosis for cardiovascular conditions.

article thumbnail

Ensight-AI Awarded FDA’s Breakthrough Device Designation for Its ECGVision-TTR Technology for Early Detection of ATTR-Cardiomyopathy

DAIC

Food and Drug Administration’s ( FDA ) Breakthrough Device Designation for their ECGvision-TTR Technology for early detection of ATTR-Cardiomyopathy. Food and Drug Administration’s (FDA) Breakthrough Devices Program , which provides patients with timely access to innovative medical devices.

article thumbnail

SS Innovations’ SSi Mantra Surgical Robotic System used to perform Mitral Valve Replacement

DAIC

milla1cf Mon, 03/18/2024 - 07:30 March 18, 2024 — SS Innovations International, Inc. , Dr. Srivastava said: “SS Innovations is dedicated to improving patient access and optimizing surgical outcomes with our accessible and cost-effective surgical robotic system. The mitral valve disease market size was valued at $2.5